Study finds potential for antidiabetic drugs to modify osteoarthritis risk

FHS
August 21, 2024
11:26 am

Whether antidiabetic medications could potentially be used as disease-modifying osteoarthritis drugs or DMOADs for the therapeutic management of osteoarthritis.

Columbia Care Q2 Revenue Increases 4% Sequentially to $129.2 Million

Columbia Care Reports Second Quarter 2023 Results NEW YORK–(BUSINESS WIRE), August 14, 2023–Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the

August 14, 2023

Ionis flashes new Angelman syndrome data, will pursue Phase 3 trial next year

Ionis on Monday revealed new six-month data from its Angelman syndrome program, presenting Phase 1/2a results from a pooled group of patients taking three different

July 23, 2024

Study highlights vaccine rollout inequities in New York City

Despite vaccine shortages, many younger people in New York City accessed vaccines ahead of schedule, particularly in high-income areas, according to new research at Columbia

April 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.